Early research indicates grey flu is entering non-lethal mutation, says Xia-Hifa head of viral studies

Xia-Hifa Biologics and Pandora Haze Technologies to jointly fund new bionic limb study

New synthetic skin developed by Xia-Hifa approved for human trials

ANNIE discussion dominates latest IJANI


"Haemorrhaging Data: How Scientists Raced to Contain Junin 2" by Alejandra Cruz wins Pulitzer

Arenovir patents projected to raise Xia-Hifa valuation by 42%

X-H3 granted Fast Track Status by MHRA

Hyperpath wins Business Monthly award

Xia-Hifa in talks with UK government for tax exempt status

A year since the Junin 2 epidemic, we talk to Alex Zedong, CEO of Xia-Hifa Biologics


New health initiative: how Xia-Hifa can help you secure your future

Xia-Hifa expands funding in local communities